You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gemcitabine

Showing 76 - 100 of 1,157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

Recruiting
  • Untreated Resectable Pancreatic Adenocarcinoma
  • +2 more
  • Paclitaxel protein bound
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
May 10, 2022

Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

Recruiting
  • Incidental Gallbladder Carcinoma
  • Biliary Tract Cancer
  • Gemcitabine
  • +3 more
  • Frankfurt, Germany
    Krankenhaus Nordwest gGmbH
Sep 7, 2022

Cervical Carcinoma Trial in La Jolla (Intensity Modulated Radiation Therapy (IMRT), Cisplatin, Gemcitabine)

Completed
  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
Feb 16, 2022

Urothelial Carcinoma, Locally Advanced, Unresectable Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Urothelial Carcinoma
  • +2 more
  • Chicago, Illinois
  • +8 more
Dec 23, 2022

Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)

Active, not recruiting
  • Unresectable Pancreatic Carcinoma
  • Herlev, Denmark
  • +1 more
Mar 15, 2022

Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel

Completed
  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 10, 2022

Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))

Completed
Has Results
  • Pancreatic Cancer
  • Gemcitabine
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Cancer Centers
Feb 10, 2022

NSCLC Trial in Rozzano (Pemetrexed/Carboplatin, Gemcitabine)

Terminated
  • NSCLC
  • Rozzano, Milan, Italy
    Istituto Clinco Humanitas
Sep 8, 2022

Locally Advanced Pancreatic Cancer (LAPC) Trial in Herlev (Gemcitabine, Nab-paclitaxel, Nivolumab)

Recruiting
  • Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
  • Gemcitabine
  • +4 more
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Oct 13, 2022

Urothelial Carcinoma Trial in United States (Gemcitabine, Cisplatin, Ipilimumab)

Completed
Has Results
  • Urothelial Carcinoma
  • Gemcitabine
  • +2 more
  • Duarte, California
  • +7 more
Jul 7, 2022

Diffuse Intrinsic Pontine Glioma Trial in Aurora (Gemcitabine)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Gemcitabine
  • Aurora, Colorado
    Children's Hospital Colorado
Jan 31, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV Trial (SBP-101, Nab-paclitaxel,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • +2 more
  • (no location specified)
Feb 21, 2022

Lung Cancer Trial in Nashville (Pemetrexed, Gemcitabine)

Completed
Has Results
  • Lung Cancer
  • Nashville, Tennessee
    Tennessee Oncology
Feb 21, 2022

Bladder Cancer, Metastatic Bladder Cancer, Urothelial Carcinoma Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Hartford, Connecticut
  • +10 more
Nov 23, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

Advanced Adenocarcinoma, Metastatic Adenocarcinoma Trial in Philadelphia (Hydroxychloroquine (HCQ), Gemcitabine, Abraxane)

Completed
  • Advanced Adenocarcinoma
  • Metastatic Adenocarcinoma
  • Hydroxychloroquine (HCQ)
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Pancreas Cancer Trial in New York (Bethanechol, Gemcitabine, nab-paclitaxel)

Recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Medical Center
Feb 3, 2022

Leiomyosarcoma, Adult Trial in France (Association of berzosertib with gemcitabine, Gemcitabine)

Recruiting
  • Leiomyosarcoma, Adult
  • Association of berzosertib with gemcitabine
  • Gemcitabine
  • Bordeaux, France
  • +5 more
Jul 27, 2022

Diffuse Large B-cell Lymphoma Trial in Chapel Hill (Polatuzumab vedotin (PV), Rituximab, Hyaluronidase)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Polatuzumab vedotin (PV)
  • +6 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Aug 9, 2022

Urinary Bladder Tumors Trial in San Antonio (AGEN1884, AGEN2034, Cisplatin)

Active, not recruiting
  • Urinary Bladder Neoplasms
  • San Antonio, Texas
    Mays Cancer Center
Mar 11, 2022

Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Oct 14, 2021

Pancreatic Cancer, Metastatic Adenocarcinoma Trial in Winston-Salem (Nab paclitaxel, Gemcitabine, TheraBionic)

Not yet recruiting
  • Pancreatic Cancer
  • Metastatic Adenocarcinoma
  • Nab paclitaxel
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Mar 8, 2023